Biointron is excited to announce our participation in World ADC Asia 2025, set to take place in Incheon, South Korea, from June 10-12, 2025. This premier event is dedicated to accelerating the development of antibody-drug conjugates (ADCs), uniting experts from across the biopharmaceutical industry to share insights, showcase innovations, and drive forward the future of targeted therapeutics.
As a leader in antibody discovery and engineering, Biointron recognizes the crucial role of ADCs in transforming cancer treatment and other therapeutic areas. Our team is committed to advancing the science behind ADCs by delivering high-quality, customized antibody solutions that optimize drug efficacy, specificity, and safety.
At World ADC Asia 2025, we look forward to engaging in key discussions on emerging ADC technologies, collaborating with industry leaders, and sharing our expertise in antibody development to propel innovation in this rapidly evolving field. We invite you to connect with us to learn how Biointron’s antibody engineering expertise can support your ADC development goals.
For more details about the event, please visit the World ADC Asia 2025 website [https://worldadc-asia.com/]
Time: June 10-12, 2025
Location: Incheon, South Korea
Booth: #TBD
